Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Esophageal Achalasia01:27

Esophageal Achalasia

45
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide...
45
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

943
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

2.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Dysrhythmias I: Introduction01:15

Dysrhythmias I: Introduction

730
Dysrhythmias refers to abnormalities in the heart's rhythm. They result from disruptions in the heart's electrical conduction system, which includes the sinoatrial(SA)node, atrioventricular(AV) node, the bundle of His, bundle branches, and Purkinje fibers.Definition and PathophysiologyDysrhythmias result from disorders of impulse formation, impulse conduction, or both. The heart contains specialized cells in the sinoatrial node, atrioventricular node, and the bundle of His and Purkinje fibers...
730
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

1.9K
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
1.9K
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

52
Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
52

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Practical Guide to Chromosome Microarray Interpretation for Paediatricians.

Journal of paediatrics and child health·2026
Same author

The use of JAK inhibitors and tocilizumab in the management of TRAPS: a sibling case study.

Pediatric rheumatology online journal·2026
Same author

Optimization and <i>In Vivo</i> Characterization of a Series of Cbl‑b Inactive-State Inhibitors.

ACS medicinal chemistry letters·2026
Same author

The quality-of-life impacts and economic burden of X-linked retinitis pigmentosa caused by variants in RPGR.

Eye (London, England)·2026
Same author

NK cell dysfunction and interferon-γ production underlie autoinflammation in mevalonate kinase deficiency.

Immunity·2026
Same author

A severe neurodevelopmental syndrome linked to a South Asian founder variant in the UFMylation adaptor CDK5RAP3.

Acta neuropathologica·2026

Related Experiment Video

Updated: May 2, 2026

Targeting Gray Rami Communicantes in Selective Chemical Lumbar Sympathectomy
03:59

Targeting Gray Rami Communicantes in Selective Chemical Lumbar Sympathectomy

Published on: January 10, 2019

6.6K

CHARGE syndrome: a review.

Peter Hsu1, Alan Ma, Meredith Wilson

  • 1Department of Allergy and Immunology, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.

Journal of Paediatrics and Child Health
|February 20, 2014
PubMed
Summary
This summary is machine-generated.

CHARGE syndrome is a complex genetic disorder caused by CHD7 gene mutations. This review covers its diagnosis, clinical features, and management strategies for affected individuals.

Keywords:
ENTbehaviouralendocrinologygeneticsimmunology

More Related Videos

Establishment of Central Cord Syndrome Model in C57BL/6J Mouse
06:36

Establishment of Central Cord Syndrome Model in C57BL/6J Mouse

Published on: September 8, 2023

1.6K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.3K

Related Experiment Videos

Last Updated: May 2, 2026

Targeting Gray Rami Communicantes in Selective Chemical Lumbar Sympathectomy
03:59

Targeting Gray Rami Communicantes in Selective Chemical Lumbar Sympathectomy

Published on: January 10, 2019

6.6K
Establishment of Central Cord Syndrome Model in C57BL/6J Mouse
06:36

Establishment of Central Cord Syndrome Model in C57BL/6J Mouse

Published on: September 8, 2023

1.6K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.3K

Area of Science:

  • Genetics
  • Pediatrics
  • Medical Genetics

Background:

  • CHARGE syndrome is a rare, complex genetic disorder.
  • It results from mutations in the CHD7 gene.
  • The syndrome affects multiple organ systems, leading to a wide spectrum of clinical manifestations.

Purpose of the Study:

  • To provide a comprehensive overview of CHARGE syndrome.
  • To discuss current understanding of its diagnosis and clinical features.
  • To outline current management approaches for individuals with CHARGE syndrome.

Main Methods:

  • This is a review article.
  • Information was gathered from existing literature and clinical expertise.
  • Key aspects of diagnosis, clinical presentation, and management were synthesized.

Main Results:

  • CHARGE syndrome presents with a characteristic pattern of anomalies, though variable.
  • Early and accurate diagnosis is crucial for timely intervention.
  • Multidisciplinary management is essential to address the diverse health needs.

Conclusions:

  • CHARGE syndrome requires a thorough understanding of its genetic basis and clinical spectrum.
  • Effective management relies on a coordinated, multidisciplinary approach.
  • Continued research is needed to improve outcomes for individuals with CHARGE syndrome.